{"nct_id":"NCT06467357","title":"Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-08-12","start_date_type":"ACTUAL","primary_completion_date":"2028-06-12","primary_completion_date_type":"ESTIMATED","completion_date":"2029-05-16","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}